|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01246 BOILLHEALTHCARE
Nominal 
0.021 0.000 (0.000%) | 2022/03 - Final HKD(K$) | %Chg (Compare to Final) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | 2019/03 HKD(K$) | 2018/03 HKD(K$) | |
| Turnover | 1,016,162 | 368.904% | 216,710 | 106,352 | 419,762 | 738,147 |
| Cost of Sales | (907,740) | 359.060% | (197,739) | (95,563) | (430,208) | (824,201) |
| Gross Profit | 108,422 | 471.514% | 18,971 | 10,789 | (10,446) | (86,054) |
| 2022/03 - Final HKD(K$) | %Chg (Compare to Final) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | 2019/03 HKD(K$) | 2018/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | (631,164) | -- | 566 | (65,654) | -- | (22,557) | |
| Change in FV & Impairment on Others | (1,850) | 72.253% | (1,074) | (2,960) | (8,725) | 65,593 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (17,721) | 1785.213% | (940) | (3,599) | (14,661) | (11,242) | |
| Profit / (Loss) before Taxation | (744,781) | 312.326% | (180,629) | (202,919) | (225,853) | (231,264) | |
| Taxation | (10,954) | -- | 5,139 | (20,875) | 1,986 | 9,208 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | 389 | |
| Non-controlling Interests | 237,937 | 620.934% | 33,004 | 34,362 | 23,753 | 7,892 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (517,798) | 263.403% | (142,486) | (189,432) | (200,114) | (213,775) | |
| 2022/03 - Final HKD(K$) | %Chg (Compare to Final) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | 2019/03 HKD(K$) | 2018/03 HKD(K$) | |
| Net Finance Costs / (Income) | 121,631 | 1.436% | 119,909 | 77,606 | 77,751 | 79,099 |
| Depreciation & Amortisation | 22,352 | 13.243% | 19,738 | 9,949 | 11,812 | 27,193 |
| Directors' Emoluments | 1,100 | 0.000% | 1,100 | 1,200 | 3,627 | 3,368 |
| 2022/03 - Final | %Chg (Compare to Final) | 2021/03 | 2020/03 | 2019/03 | 2018/03 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2022/03 - Final | %Chg (Compare to Final) | 2021/03 | 2020/03 | 2019/03 | 2018/03 | |
| EPS (cts) | -38.130 | 200.236% | -12.700 | -20.880 | -22.100 | -23.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.084) | -- | (0.137) | 0.080 | 0.469 | 0.033 |
| NBV per share ($) | (0.008) | -- | 0.343 | 0.449 | 0.702 | 1.005631 |
| Remarks: | Real time quote last updated: 06/03/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -118,640,000 |
| %Change | -72.297% |
| EPS / (LPS) | HKD -0.087 |
| NBV Per Share ($) | HKD -0.245 |